Second line protease inhibitor (PI/r) based antiretroviral therapy (ART) after non-nucleoside reverse transcriptase inhibitor (NNRTI) failure: impact of nucleoside (NRTI) backbone-Reference-Cited by-同舟云学术

Second line protease inhibitor (PI/r) based antiretroviral therapy (ART) after non-nucleoside reverse transcriptase inhibitor (NNRTI) failure: impact of nucleoside (NRTI) backbone

Published:2012 Issue:2 Volume:18 Page:213-219
ISSN:1359-6535
Container-title:Antiviral Therapy
language:
Short-container-title:Antivir Ther

Author:

Waters Laura, , ,Bansi Loveleen,Asboe David,Pozniak Anton,Smit Erasmus,Orkin Chloe,Fearnhill Esther,Dunn David,Phillips Andrew

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir;AIDS Research and Human Retroviruses;2018-06

2. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial;The Lancet HIV;2017-09

3. Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial;The Lancet HIV;2017-08

4. Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort;Journal of Antimicrobial Chemotherapy;2017-04-06

5. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015;HIV Medicine;2016-08